Neurontin Off-Label Use Needs Prior Authorization Under Fla. Medicaid Plan
Executive Summary
Prior authorization for off-label use of Pfizer's Neurontin would save the Florida Medicaid program $7 mil., the FY 2004-2005 budget proposal states
You may also be interested in...
Zyprexa Removal From Florida Medicaid Drug List Recommended By P&T Cmte
Use of Lilly's antipsychoticZyprexa would require prior authorization under Florida's Medicaid program should the state approve recommendations by a pharmacy & therapeutics committee
Zyprexa Removal From Florida Medicaid Drug List Recommended By P&T Cmte
Use of Lilly's antipsychoticZyprexa would require prior authorization under Florida's Medicaid program should the state approve recommendations by a pharmacy & therapeutics committee
Geodon, Abilify Have Low Diabetes Risk, ADA Says; Lilly Disagrees
An American Diabetes Association "consensus" statement on antipsychotics and the risk of diabetes may help Pfizer and Bristol-Myers Squibb make the case to FDA to exempt Geodon and Abilify from class labeling